International pharmaceutical company GM PHARMA participated in CPHI Milan 2026, one of the world's most significant international exhibitions for the pharmaceutical industry. With its own dedicated exhibition stand, the company held a series of business meetings with pharmaceutical industry representatives from around the world, focusing on establishing new partnerships and strengthening existing collaborations.
CPHI is one of the world's largest international pharmaceutical exhibitions. Established in 1990, the event has been bringing together leading pharmaceutical companies, manufacturers, innovators and industry professionals for 36 years.
The 2026 exhibition brought together more than 62,000 industry professionals and over 2,400 companies from across the globe. CPHI serves as a major international business platform, facilitating strategic partnerships, showcasing innovative technologies and fostering global collaboration within the pharmaceutical industry.
For many years, GM PHARMA has proudly represented Georgia’s pharmaceutical industry at CPHI Worldwide, one of the world’s leading pharmaceutical exhibitions, showcasing its capabilities, achievements, and international ambitions through its own exhibition stand each year.
During the exhibition, GM PHARMA representatives engaged in discussions with international partners on new opportunities for collaboration, advancements in pharmaceutical manufacturing, technological innovations and prospects for long-term strategic partnerships.
One of the key priorities of GM PHARMA's international expansion strategy is to establish new partnerships and broaden its geographical presence. The company places particular emphasis on strengthening its position in the European market while exploring opportunities for cooperation across Southeast Asia, South America and Central America.
Participation in CPHI Milan 2026 provided GM PHARMA with an opportunity to showcase its manufacturing and technological capabilities, product portfolio and future development plans to international business partners.
For GM PHARMA, annual participation in CPHI represents an important opportunity to reinforce its position in international markets, identify new business opportunities and enhance the global visibility of Georgia's pharmaceutical industry.
GM PHARMA continues to expand its international partnership network and implement its global expansion strategy, with the aim of entering new markets and strengthening its position within the international pharmaceutical industry.
GM PHARMA is an international pharmaceutical company with 27 years of experience in the Georgian market. GM PHARMA’s state-of-the-art pharmaceutical manufacturing facility is located in Tbilisi, Georgia, and is recognized as one of the leading pharmaceutical manufacturing facilities in the Caucasus region. Equipped with advanced technologies, the facility supports the complete manufacturing cycle for solid dosage forms. All manufacturing processes are carried out in full compliance with national and international quality standards.
GM PHARMA remains committed to continuous development and the pursuit of new opportunities. The company actively participates in international pharmaceutical initiatives, placing strong emphasis on technological innovation and the expansion of strategic partnerships. Driven by science, strengthened by international expertise, and supported by advanced technologies, GM PHARMA continues to shape a healthier future by advancing pharmaceutical innovation and improving patients’ lives.